Showing results (1101-1110 of 5,010) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|December 10, 1997
A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapyJ O Park, S Y Rha, N C Yoo, et al.American Journal of Clinical Oncology|December 10, 1997
Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicityR Pazdur, C Meyers, E Diaz-Canton, et al.American Journal of Clinical Oncology|December 10, 1997
Secondary syringomyelia due to intramedullary spinal cord metastasis. Case report and review of literatureY K Keung, E Cobos, R P Whitehead, et al.American Journal of Clinical Oncology|December 10, 1997
Neoadjuvant chemotherapy followed by concurrent chemotherapy and radiotherapy for locally advanced esophageal carcinoma with bulky upper abdominal lymphadenopathy. Case reportH Sueyama, K Sakai, T Sugita, et al.American Journal of Clinical Oncology|December 10, 1997
The heterogeneity of leukemia occurring after treatment for sarcomaM Varterasian, M Zalupski, C KaranesAmerican Journal of Clinical Oncology|December 10, 1997
Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazoleC A Jamis-Dow, M L Pearl, P B Watkins, et al.American Journal of Clinical Oncology|August 1, 1997
Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell cancer of the bladder: a Southwest Oncology Group trialJ A Kish, M K Wolf, P F Schellhammer, et al.American Journal of Clinical Oncology|August 1, 1997
Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapyH K Kim, A F Thornton, H S Greenberg, et al.American Journal of Clinical Oncology|August 1, 1997
Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancerN Ramnath, P LoRusso, M Simon, et al.American Journal of Clinical Oncology|August 1, 1997
Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancerM Colleoni, C Graiff, G Vicario, et al.Pageof 501